 |
|
|
 = Add Release to Briefcase |
| All 2007 Releases |
|---|
 |
ZIOPHARM to Present at the BMO Capital Markets Focus on Healthcare Conference
Dec 3, 2007
|
7.7 KB
|
| |
NEW YORK, Dec 03, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that Dr. Jonathan Lewis, Chief Executive Officer, will present at the BMO Capital Markets Focus on Healthcare Conference on Tuesday December 4, 2007 at 2:00 p.m. ET at the Millennium Broadway Hotel in New York, NY. Dr. Lewis will provide an overview of ...
|
|
|
ZIOPHARM to Host Analyst & Institutional Investor Meeting
Nov 15, 2007
|
9.3 KB
|
| |
NEW YORK, Nov 15, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that the Company will host an analyst and institutional investor meeting on Thursday, November 29, 2007 from 7:30 A.M. to 10:00 A.M. Eastern Time at The Yale Club of New York City (50 Vanderbilt Avenue between E. 44th & E. 45th Streets). Presentations a...
|
|
|
ZIOPHARM Presents Positive Phase II Data for ZIO-201 in Soft Tissue and Bone Sarcomas at Connective Tissue Oncology Society (CTOS) Annual Meeting
Nov 5, 2007
|
14.7 KB
|
| |
NEW YORK, Nov 05, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today the presentation of positive data from an ongoing Phase II study of ZIO-201 used in soft tissue and bone sarcomas at the Connective Tissue Oncology Society (CTOS) Annual Meeting which was held in Seattle, Washington from November 1-3, 2007.
The Phas...
|
|
|
ZIOPHARM Oncology Reports Third Quarter Results
Nov 2, 2007
|
14.2 KB
|
| |
NEW YORK, Nov 02, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP), a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs, today reported financial results for the three and nine months ended September 30, 2007.
...
|
|
|
ZIOPHARM Oncology to Present at MASS Opps Partnering Forum
Nov 1, 2007
|
11.7 KB
|
| |
NEW YORK, Nov 01, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that Dick Bagley, President and COO will present at the MASS Opps Partnering Forum on Thursday, November 8, 2007 at 10:55 am ET at the Hilton Boston Logan Airport in Boston, MA. Mr. Bagley will provide an overview of the Company and an update on its cli...
|
|
|
ZIOPHARM to Present at Rodman & Renshaw 9th Annual Healthcare Conference
Oct 29, 2007
|
12.1 KB
|
| |
NEW YORK, Oct 29, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that Dr. Jonathan Lewis, Chief Executive Officer, will present at the Rodman & Renshaw 9th Annual Healthcare Conference on Monday, November 5, 2007 at 2:40 p.m. ET at the Palace Hotel in New York, NY. Dr. Lewis will provide an overview of the Company an...
|
|
|
Clinical and Preclinical Data for Oral Indibulin (ZIO-301) Presented at AACR/NCI/EORTC Conference
Oct 25, 2007
|
15.1 KB
|
| |
SAN FRANCISCO, Oct 25, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today the presentation of two posters reporting clinical and pre-clinical data for the oral administration of indibulin (ZIO-301) at the Molecular Targets and Cancer Therapeutics Conference, an international conference hosted by the American Association ...
|
|
|
ZIOPHARM to Present at the BIO Investor Forum
Oct 3, 2007
|
12.1 KB
|
| |
NEW YORK, Oct 03, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that Dr. Barbara Wallner, Senior Vice President, Technical Operations and Chief Technology Officer, will present at the BIO Investor Forum on Wednesday, October 10, 2007 at 10:45 a.m. PT (1:45 ET) at the Palace Hotel in San Francisco, CA. Dr. Wallner wi...
|
|
|
ZIOPHARM to Present at Natexis Bleichroeder's Hidden Gems Conference
Oct 1, 2007
|
12.1 KB
|
| |
NEW YORK, Oct 01, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that Dr. Jonathan Lewis, Chief Executive Officer, will present at the Natexis Bleichroeder's Hidden Gems Conference on Monday, October 8, 2007 at 3:45 p.m. ET at the Carlton Hotel in New York, NY. Dr. Lewis will provide an overview of the Company and an...
|
|
|
Data From Ongoing Hematological Trials With Darinaparsin Presented at European College of Clinical Oncology Annual Meeting
Sep 25, 2007
|
13.8 KB
|
| |
BARCELONA, Spain, Sep 25, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP), announced today the presentation of data from ongoing clinical trials of darinaparsin (ZIO-101) to treat advanced hematological malignancies. The data were presented yesterday at the 14th Annual European Cancer Conference (ECCO) meeting being held in Barcelona...
|
|
|
Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European College of Clinical Oncology Annual (ECCO) Meeting
Sep 25, 2007
|
14.8 KB
|
| |
BARCELONA, Spain, Sep 25, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announces that positive interim data from an ongoing phase II trial of ZIO-201 (isophosphoramide mustard- IPM) to treat refractory sarcoma patients were presented by Rashmi Chugh, MD, Principal Investigator from the University of Michigan at the 14th Annual Eur...
|
|
|
ZIOPHARM to Present at the UBS Global Life Sciences Conference
Sep 19, 2007
|
12.1 KB
|
| |
NEW YORK, Sep 19, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that Dr. Jonathan Lewis, Chief Executive Officer, will present at the UBS Global Life Sciences Conference on Wednesday, September 26, 2007 at 4:30 p.m. ET at the Grand Hyatt in New York. Dr. Lewis will provide an overview of the Company and an update on...
|
|
|
ZIOPHARM to Present at the G5: ThinkEquity Partners 5th Annual Growth Conference
Sep 11, 2007
|
12.1 KB
|
| |
NEW YORK, Sep 11, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that Dr. Jonathan Lewis, Chief Executive Officer, will present at the G5: ThinkEquity Partners 5th Annual Growth Conference on Monday, September 17, 2007 at 9:00 a.m. PT (noon ET) at the St. Regis Hotel in San Francisco, CA. Dr. Lewis will provide an ov...
|
|
|
ZIOPHARM Treats Patients in U.S. Phase I Trials of Oral Darinaparsin and Indibulin
Sep 10, 2007
|
15.0 KB
|
| |
NEW YORK, Sep 10, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that the company has begun dosing patients in a U.S. phase I trial of its oral formulation of darinaparsin (ZIO-101) to treat solid tumors. The Company has also initiated patient treatment in a U.S. phase I trial of the oral formulation of indibulin (ZI...
|
|
|
ZIOPHARM Oncology Reports Second Quarter Results
Aug 13, 2007
|
13.8 KB
|
| |
NEW YORK, Aug 13, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP), a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs, today reported financial results for the three- and six-month periods ended June 30, 2007.
...
|
|
|
ZIOPHARM to Present at ThinkEquity Think Big Conference
Jul 26, 2007
|
11.6 KB
|
| |
NEW YORK, Jul 26, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that Dr. Jonathan Lewis, Chief Executive Officer, will present at the ThinkEquity Think Big Conference on Thursday, August 2, 2007 at 9:45 a.m. ET at the Mandarin Oriental Hotel, New York. Dr. Lewis will provide an overview of the Company and an update ...
|
|
|
Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
Jul 9, 2007
|
13.7 KB
|
| |
LUGANO, Switzerland, Jul 09, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announces that positive interim data from an ongoing phase II trial of ZIO-201 (isophosphoramide mustard - IPM) to treat advanced sarcoma patients was presented at the European Society of Medical Oncology (ESMO) meeting held July 5-8, 2007 in Lugano, Switzer...
|
|
|
ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Jul 6, 2007
|
11.6 KB
|
| |
NEW YORK, Jul 06, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that Dr. Jonathan Lewis, Chief Executive Officer, will present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference on Thursday, July 12, 2007 at 2:30 p.m. ET at the Mandarin Oriental Hotel, New York. Dr. Lewis will provide an overview...
|
|
|
ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
Jun 28, 2007
|
14.4 KB
|
| |
KOS, Greece, Jun 28, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP), announced today the presentation of two posters at the XIth Annual International Myeloma Workshop being held in Kos, Greece from June 25-28th, 2007. The meeting highlights important advances made in the biology and treatment of multiple myeloma. ZIOPHARM is present...
|
|
|
ZIOPHARM Oncology Selected To Join Russell 3000(R)
Jun 25, 2007
|
11.4 KB
|
| |
NEW YORK, Jun 25, 2007 (BUSINESS WIRE) -- ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced that it has been selected for inclusion in the Russell Microcap(R), 3000(R), and Global(R) Indexes, effective immediately.
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passiv...
|
|
|
| |
Recent Releases
Sep 7, 2010
ZIOPHARM Oncology to Present at the Rodman & Renshaw Annual Global Investment Conference
Aug 4, 2010
ZIOPHARM Oncology to Present at the Canaccord Genuity 30th Annual Global Growth Conference
Jul 30, 2010
ZIOPHARM Reports Second Quarter Financial Results and Updates Clinical Programs
more »
|
